drug
saxagliptin
Marketedupdated 3mo agoby Glenmark Pharmaceuticals Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- companyGlenmark Pharmaceuticals Ltd6 co-mentions · 2 sources
- drugDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE4 co-mentions · 2 sources
- drugDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE4 co-mentions · 2 sources
- drugDAPAGLIFLOZIN4 co-mentions · 2 sources
- tagApproval4 co-mentions · 2 sources
- tagSmall Molecule2 co-mentions · 2 sources
- tagRecall2 co-mentions · 2 sources
indications
investigational
Type 2 Diabetes
all catalysts(0)
nothing on the calendar yet
Trials studying saxagliptin
- N/APre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- phase3Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers
- phase4To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients
- —Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
- phase4Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
- phase3Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
- phase4Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 28m ago
Found something off?
comments(0)
5-min edit window · permanent after that